Establishment Labs Holdings Inc. ESTA

FY2025 · ended Dec 31, 2025 · Revenue $211.08M, +27.1% YoY · Filed Feb 27, 2026

Establishment Labs Holdings Inc. (ESTA) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $211.1 million and a net loss of $51.1 million. Free cash flow was -$56.9 million. As of Jun 30, 2026 it held $71.2 million in cash and investments and $263.7 million in total debt.

Revenue (TTM)
$245.82M
+38.6% vs year-ago TTM
Net income (TTM)
$-38.89M
+56.1% vs year-ago TTM
Operating cash flow (TTM)
$-32.32M
+55.5% vs year-ago TTM
Free cash flow (TTM)
$-41.51M
+46.1% vs year-ago TTM
EPS (TTM)
$-1.29
+58.2% vs year-ago TTM
Dividend per share
None
Shares outstanding
29.32M
+1.6% vs prior year
Net cash
$-192.52M
as of Jun 30, 2026
Operating margin
-7.6%
FY 2026

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
ESTA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Virgin Islands, British
Headquarters
Alajuela, Costa Rica
SEC filer status
Large accelerated filer
SEC CIK
1688757

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$211.1M
$166.0M
$165.2M
$161.7M
$126.7M
Operating income
-$39.0M
-$50.0M
-$65.0M
-$39.7M
-$25.1M
Net income
-$51.1M
-$84.6M
-$78.5M
-$75.2M
-$41.1M
Diluted EPS
-$1.72
-$3.00
-$3.07
-$3.08
-$1.72
Operating cash flow
-$50.9M
-$58.5M
-$88.5M
-$52.2M
-$27.5M
Free cash flow
-$56.9M
-$64.6M
-$96.4M
-$55.0M
-$30.0M
Total assets
$357.2M
$346.8M
$268.6M
$211.1M
$139.5M
Total liabilities
$333.6M
$293.7M
$250.2M
$219.2M
$88.8M
Stockholders' equity
$23.5M
$53.1M
$18.4M
-$8.2M
$50.7M
Cash and investments
$75.6M
$90.3M
$40.0M
—
—
Total debt
$252.1M
$225.3M
$192.2M
$3.9M
$2.3M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Oct 29, 2026 Oct 29, 2026
8-K Current report
Material agreement
Oct 15, 2026 Oct 14, 2026
10-Q Quarterly report Aug 7, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 29, 2026 Jun 29, 2026
8-K Current report
Shareholder vote results
May 22, 2026 May 22, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.